ZNF408 inhibitors, as found in the above tabulation, represent a collection of chemicals primarily poised to indirectly modulate the functional context or activity of ZNF408. Given that zinc finger proteins like ZNF408 often serve as DNA-binding entities that modulate transcription, the chosen inhibitors target processes that can influence the DNA-binding and transcription-regulating functions of this protein. For instance, Decitabine is a cytidine analog that induces DNA hypomethylation. This alteration in methylation patterns can modify the DNA landscape, influencing the binding dynamics of ZNF408.
Another pivotal approach to modulate ZNF408's function is to target the chromatin state. Actinomycin D and Mithramycin A interact directly with DNA, competing with ZNF408 for binding. The inclusion of transcription inhibitors such as Alphitolic acid, DRB, and Triptolide stems from the role of ZNF408 in transcriptional regulation. These compounds target RNA polymerase II, providing a comprehensive inhibition of transcription, and thereby impacting ZNF408's transcription-regulating roles. Lastly, Geldanamycin's ability to inhibit Hsp90 showcases a broader approach, as Hsp90 client proteins or interacting partners can influence the stability or function of ZNF408 in the cellular context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase (HDAC) inhibitor that alters chromatin structure, potentially affecting ZNF408 binding sites accessibility. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Analog of cytosine that causes DNA hypomethylation, which might modify the accessibility of DNA regions for ZNF408. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Intercalates into DNA, disrupting the function of DNA-binding proteins like ZNF408. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to GC-rich DNA sequences, which can compete with ZNF408 if its target sequences overlap. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Alters endosomal pH, potentially affecting post-translational modifications of proteins like ZNF408. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II, thus potentially impacting the transcriptional activities of ZNF408. | ||||||
Ikarugamycin | 36531-78-9 | sc-202179 | 500 µg | $185.00 | 4 | |
Inhibits nuclear import by binding importin, which might affect the nuclear localization and function of ZNF408. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Inhibits RNA polymerase II, impacting transcriptional activities where ZNF408 might play a role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor which might indirectly modulate pathways or proteins that interact with or modify ZNF408. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Hsp90 inhibitor that affects many client proteins, and could influence ZNF408 if it's a client protein or interacts with one. | ||||||